摘要
目的了解本地区HIV合并丙型肝炎病毒(HCV)感染情况以及预防措施。方法对2003～2008年来我院作介入治疗和检查的住院及门诊病人22054例,用北京万泰生物药业生产的酶联免疫吸附试剂(ELISA)作抗HIV(1+2型)和HCV抗体检测,雅培抗HIV金标试纸条进行HIV抗体初筛试验。结果22054份血清标本中HIV抗体阳性254份,单纯抗HIV阳性110例,HIV抗体阳性同时合并HCV抗体阳性153例,结论HIV感染者由于抗感染力低下,易于同时合并HCV感染,是威胁艾滋病人并导致其死亡的重要原因。
Objective To find out HIV concurrent infection HCV virus＇s situation and preventive measure in our area. Method For 22054 patient who contained in hospital＇s patient and outpatient from 2003-2008, using ElASA reagent detected HIV and HCV antibody; Using HIV test card carried out preliminary screening. Result In 22054 sample ,HIV antibody positive is 254, there are 153 HCV concurrent infection HIV positive, there are 110 sample for HIV positive. Conclusion The patient＇s resistance who had infected HIV reduced, so it is easy to the patient concurrent infected HCV. It is a important cause of death for HIV patient.
出处
《当代医学》
2009年第32期1-1,共1页
Contemporary Medicine
